Tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol) as a beta-adrenergic blocker.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000319:Adrenergic beta-Antagonists; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000201:enzymology; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms; D009206:Myocardium / Q000201:enzymology; D011412:Propanolamines / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D013844:Thiazoles / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D013844:Thiazoles; C002268:tazolol; D000262:Adenylyl Cyclases; D007545:Isoproterenol